Anesth Analg 2007;105:487-494
© 2007 International Anesthesia Research Society
doi: 10.1213/01.ane.0000267260.00384.d9
ANALGESIA
Adenosine as a Non-Opioid Analgesic in the Perioperative Setting
Tong J. Gan, MB, FRCA, FFARCSI, and
Ashraf S. Habib, MB, FRCA
From the Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.
Address correspondence and reprint requests to Tong J. Gan, MD, Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710. Address e-mail to GAN00001{at}mc.duke.edu.
Abstract
Adenosine, a ubiquitous metabolic intermediate in the body, is involved in nearly every aspect of cell function, including neuromodulation and neurotransmission. Adenosine A1 and A2 receptors are widely distributed in the brain and spinal cord, and are a novel, non-opiate target for pain management. The potential of adenosine as a non-narcotic analgesic in anesthetized patients has been explored in clinical trials, including double-blind studies versus placebo and remifentanil infusion. These studies suggest that, compared to placebo or remifentanil, an intraoperative adenosine infusion stabilizes core hemodynamics and reduces the requirement for anesthesia during surgery. Further, adenosine improves postoperative recovery, as indicated by lower pain scores and less opioid consumption. The safety profile of adenosine has been well characterized based on use of currently approved adenosine products. The most common adverse events associated with its use include flushing, chest discomfort, dyspnea, headache, gastrointestinal discomfort, and lightheadedness. These effects are generally well tolerated and transient. Further studies are warranted to investigate the full potential of adenosine as a non-opioid analgesic in the perioperative setting.
|